Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Masimo Corporation - Common Stock (NQ: MASI )

166.09 +0.52 (+0.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Masimo Announces Select Preliminary Full-Year 2021 Financial Results and 2022 Guidance
From Masimo Corporation
Via Business Wire
New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium
From Masimo
Via Business Wire
Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India
From Masimo
Via Business Wire
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
Via Benzinga
Masimo to Present in Piper Sandler 33rd Annual Healthcare Conference
From Masimo
Via Business Wire
New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
From Masimo
Via Business Wire
Masimo to Present in Stifel 2021 Virtual Healthcare Conference
From Masimo
Via Business Wire
Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients
From Masimo
Via Business Wire
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Masimo Launches Dual SET® Pulse Oximetry
From Masimo
Via Business Wire
Masimo (MASI) Q3 2021 Earnings Call Transcript
MASI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Masimo Q3 Earnings
Masimo (NASDAQ:MASI) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Masimo beat... 
Via Benzinga
Masimo Reports Third Quarter 2021 Financial Results
From Masimo
Via Business Wire
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography
From Masimo
Via Business Wire
Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26
From Masimo
Via Business Wire
Masimo and University Hospitals Partner to Combat Nurse Burnout
From Masimo
Via Business Wire
New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
From Masimo
Via Business Wire
Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology
From Masimo
Via Business Wire
Masimo Launches Single-patient-use rainbow® SuperSensor™
From Masimo
Via Business Wire
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
From Masimo Corporation
Via Business Wire
New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
From Masimo
Via Business Wire
Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
From Masimo
Via Business Wire
Masimo SafetyNet Alert™ Launches in Western Europe
From Masimo
Via Business Wire
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
From Masimo
Via Business Wire
Masimo (MASI) Q2 2021 Earnings Call Transcript
MASI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Masimo: Q2 Earnings Insights
Shares of Masimo (NASDAQ:MASI) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 10.59% year over year to $... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.